AtriCure

AtriCure

We are passionately focused on healing the lives of those affected by Afib and pain after surgery.

Location
Roles tracked
0
In pipeline
0
Tracking since

At a glance

You're tracking 0 roles at AtriCure. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Medical Equipment Manufacturing
Company size
1,389 people
Headquarters
Mason, Ohio +4 more
Founded
2000
Type
Public Company
Total funding
$207.0M

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists, cardiothoracic and thoracic surgeons around the globe use AtriCure technologies for the treatment of Afib, reduction of Afib related complications and post-operative pain management. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE®+ and cryoSPHERE MAX™ probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on X (formerly Twitter) @AtriCure.

Medical Devices Manufacturing Atrial Fibrillation and Maze IV Training

Open roles at AtriCure